ArticleMuscle & nerve2026
Construct Validity and Reliability of the OMNI Scale in Children and Adolescents With Neuromuscular Diseases.
Article in Muscle & nerve, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
INTRODUCTION/
aimsChildren and adolescents with neuromuscular diseases often demonstrate muscle weakness and mobility limitations, which may increase perceived exertion during functional tasks. The OMNI scale was developed to assess perceived exertion in pediatric populations; however, its measurement properties in neuromuscular conditions remain unclear. This study aimed to examine the construct validity of the OMNI scale, using the Borg scale as a reference, and its inter-rater reliability during the 6-minute walk test (6MWT) in children and adolescents with Charcot-Marie-Tooth disease (CMT) and myopathies.
methodsConstruct validity was analyzed in 39 participants, and inter-rater reliability in 21 participants aged 4-18 years. Perceived exertion was assessed before, during, and after the 6MWT using the OMNI and Borg scales. Linear mixed-effects models examined construct validity. The intraclass correlation coefficient (ICC) and standard error of measurement (SEM) assessed reliability.
resultsA significant association was observed between Borg and OMNI scores (β = 0.82, p < 0.001). OMNI scores increased throughout the 6MWT, indicating changes in perceived exertion. Inter-rater reliability was moderate at the second minute (ICC = 0.67; 95% CI 0.34-0.85) and high at the end of the 6MWT (ICC = 0.75; 95% CI 0.48-0.89). The SEM was 1.74 points at the second minute and 1.32 points at the end of the 6MWT. DISCUSSION: The OMNI scale demonstrated good construct validity and acceptable inter-rater reliability, with low measurement error, supporting its clinical applicability. This suggests that the OMNI scale is a practical and reliable tool for monitoring perceived exertion in children and adolescents with neuromuscular diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.